Mates Sharon insider trades
Mates Sharon has filed 34 Form 4s with the SEC that we hold, for ITCI (Chairman and CEO, Director), Benitec Biopharma Inc. (BNTC) (Director) and Seaport Therapeutics, Inc. (SPTX) (Director). Across all of them we count 0 purchases worth $0 and 62 sales worth $69.3M reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 65,979 shares of ITCI worth $4.4M, dated 2024-01-16. The first filing on our record is dated 2021-08-24 and the latest 2026-05-04.
ITCI
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-10-14 | S, sale reported on Form 4 | 1,416 | $56.6K | 2021-10-18 |
| 2021-10-15 | S, sale reported on Form 4 | 40,392 | $1.6M | 2021-10-18 |
| 2021-10-18 | S, sale reported on Form 4 | 8,192 | $327.7K | 2021-10-18 |
| 2022-01-10 | S, sale reported on Form 4 | 8,954 | $359.1K | 2022-01-11 |
| 2022-01-10 | S, sale reported on Form 4 | 5,804 | $242.1K | 2022-01-11 |
| 2022-01-10 | S, sale reported on Form 4 | 27,138 | $1.1M | 2022-01-11 |
| 2022-02-22 | S, sale reported on Form 4 | 12,667 | $696.4K | 2022-02-23 |
| 2022-02-22 | S, sale reported on Form 4 | 15,180 | $846.0K | 2022-02-23 |
| 2022-02-24 | S, sale reported on Form 4 | 11,249 | $588.9K | 2022-02-25 |
| 2022-02-24 | S, sale reported on Form 4 | 11,240 | $580.1K | 2022-02-25 |
| 2022-02-24 | S, sale reported on Form 4 | 100 | $5.1K | 2022-02-25 |
| 2022-12-13 | S, sale reported on Form 4 | 33,083 | $1.8M | 2022-12-15 |
| 2023-02-21 | S, sale reported on Form 4 | 251 | $12.4K | 2023-02-22 |
| 2023-02-21 | S, sale reported on Form 4 | 2,502 | $121.8K | 2023-02-22 |
| 2023-02-21 | S, sale reported on Form 4 | 2,200 | $104.2K | 2023-02-22 |
| 2023-02-21 | S, sale reported on Form 4 | 22,895 | $1.1M | 2023-02-22 |
| 2023-02-24 | S, sale reported on Form 4 | 22,590 | $1.1M | 2023-02-27 |
| 2023-03-10 | S, sale reported on Form 4 | 34,965 | $1.5M | 2023-03-13 |
| 2023-03-10 | S, sale reported on Form 4 | 6,805 | $289.3K | 2023-03-13 |
| 2023-03-13 | S, sale reported on Form 4 | 19,153 | $863.0K | 2023-03-13 |
| 2023-03-13 | S, sale reported on Form 4 | 1,412 | $62.2K | 2023-03-13 |
| 2023-09-18 | S, sale reported on Form 4 | 28,119 | $1.5M | 2023-09-19 |
| 2023-09-18 | S, sale reported on Form 4 | 27,468 | $1.5M | 2023-09-19 |
| 2023-09-19 | S, sale reported on Form 4 | 44,413 | $2.4M | 2023-09-19 |
| 2024-01-16 | S, sale reported on Form 4 | 5,882 | $398.6K | 2024-01-18 |
| 2024-01-16 | S, sale reported on Form 4 | 65,979 | $4.4M | 2024-01-18 |
| 2024-01-16 | S, sale reported on Form 4 | 3,500 | $232.3K | 2024-01-18 |
| 2024-01-17 | S, sale reported on Form 4 | 30,633 | $2.0M | 2024-01-18 |
| 2024-01-17 | S, sale reported on Form 4 | 17,451 | $1.2M | 2024-01-18 |
| 2024-01-18 | S, sale reported on Form 4 | 320 | $21.2K | 2024-01-18 |
| 2024-01-18 | S, sale reported on Form 4 | 67,597 | $4.4M | 2024-01-18 |
| 2024-02-02 | S, sale reported on Form 4 | 16,435 | $1.1M | 2024-02-05 |
| 2024-02-02 | S, sale reported on Form 4 | 17,450 | $1.2M | 2024-02-05 |
| 2024-02-26 | S, sale reported on Form 4 | 600 | $41.0K | 2024-02-27 |
| 2024-02-26 | S, sale reported on Form 4 | 12,462 | $873.7K | 2024-02-27 |
| 2024-02-26 | S, sale reported on Form 4 | 9,528 | $661.7K | 2024-02-27 |
| 2024-03-07 | S, sale reported on Form 4 | 8,754 | $585.9K | 2024-03-11 |
| 2024-03-07 | S, sale reported on Form 4 | 31,958 | $2.1M | 2024-03-11 |
| 2024-03-11 | S, sale reported on Form 4 | 306 | $20.6K | 2024-03-11 |
| 2024-03-11 | S, sale reported on Form 4 | 14,541 | $942.3K | 2024-03-11 |
| 2024-03-11 | S, sale reported on Form 4 | 4,128 | $272.0K | 2024-03-11 |
| 2024-03-11 | S, sale reported on Form 4 | 1,590 | $106.2K | 2024-03-11 |
| 2024-08-21 | S, sale reported on Form 4 | 1,900 | $148.2K | 2024-08-23 |
| 2024-08-21 | S, sale reported on Form 4 | 2,682 | $207.1K | 2024-08-23 |
| 2024-08-21 | S, sale reported on Form 4 | 44,134 | $3.3M | 2024-08-23 |
| 2024-08-21 | S, sale reported on Form 4 | 4,297 | $327.4K | 2024-08-23 |
| 2024-08-22 | S, sale reported on Form 4 | 4,369 | $329.7K | 2024-08-23 |
| 2024-08-22 | S, sale reported on Form 4 | 35,011 | $2.6M | 2024-08-23 |
| 2024-08-23 | S, sale reported on Form 4 | 28,680 | $2.1M | 2024-08-23 |
| 2024-08-26 | S, sale reported on Form 4 | 22,713 | $1.7M | 2024-08-28 |
| 2024-08-27 | S, sale reported on Form 4 | 23,657 | $1.7M | 2024-08-28 |
| 2024-08-27 | S, sale reported on Form 4 | 16,856 | $1.2M | 2024-08-28 |
| 2024-08-28 | S, sale reported on Form 4 | 32,459 | $2.4M | 2024-08-28 |
| 2024-08-28 | S, sale reported on Form 4 | 240 | $17.7K | 2024-08-28 |
| 2024-08-29 | S, sale reported on Form 4 | 5,772 | $422.8K | 2024-08-30 |
| 2024-08-29 | S, sale reported on Form 4 | 29,832 | $2.2M | 2024-08-30 |
| 2024-08-30 | S, sale reported on Form 4 | 6,193 | $454.1K | 2024-08-30 |
| 2024-08-30 | S, sale reported on Form 4 | 28,203 | $2.1M | 2024-08-30 |
| 2024-12-04 | S, sale reported on Form 4 | 23,333 | $2.0M | 2024-12-06 |
| 2024-12-04 | S, sale reported on Form 4 | 27,667 | $2.4M | 2024-12-06 |
| 2024-12-05 | S, sale reported on Form 4 | 50,163 | $4.2M | 2024-12-06 |
| 2024-12-05 | S, sale reported on Form 4 | 1,534 | $129.9K | 2024-12-06 |
Benitec Biopharma Inc. (BNTC)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Seaport Therapeutics, Inc. (SPTX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1585699) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms